 Leukaemia & Lymphoma Research | £1 million for Southampton lymphoma drug research Leukaemia & Lymphoma Research The introduction of a monoclonal antibody called rituximab over a decade ago heralded their use as an effective treatment for cancer. It doubled the long-term survival rates for many different types of lymphoma when used in combination with chemotherapy. |
